While it is widely recognized that inherited variants of serum cholinesterase (acyl choline acyl hydrolase, E.C.3.1.1.8.) are a common cause of prolonged muscular paralysis in patients treated with succinyl choline (suxamethonium, Scoline), their possible association with other diseases is less familiar. Recently, two independent reports have appeared suggesting that a greater frequency of the fluoride-resistant cholinesterase gene (E/) occurs in patients susceptible to malignant hyperpyrexia (MH), than in the population at large (Whittaker, Spencer and Searle, 1977; Ellis, Cain et al., 1978) .
There has been no explanation for these findings, but with a further report of an increased frequency of UF heterozygotes amongst inmates of a psychiatric institution (Whittaker and Berry, 1977) , although subsequently denied by Propert (1979) , it is possible that the fluoride-resistant allele of serum cholinesterase might have hitherto unrecognized properties.
In view of the notorious difficulty of identifying UF heterozygotes (Heilbronn, 1965) using current biochemical techniques, we decided to try to confirm previous reports by investigating a large number of MH-positive patients in two laboratories experienced in cholinesterase methodology and using different systems of analysis.
Venous blood for biochemical investigation was obtained from 28 MH-positive patients drawn from 15 families who presented to the Malignant Hyperpyrexia Investigation Unit at St James's University Hospital, Leeds. Susceptibility to malignant hyperpyrexia was established by demonstrating a halothane-induced muscle contracture in vitro as described by Ellis, Harriman and others (1978) .
The following techniques were used in Leeds for the determination of cholinesterase status: activity (Evans and Wroe, 1978) ; dibucaine number (Kalow and Genest, 1957) ; fluoride number (Harris and Whittaker, 1961) .
All investigations were performed at 25 °C on a Pye Unicam SP1800 recording spectrophotometer. Propionyl thiocholine was used for measurement of activities, but inhibitor studies were undertaken using benzoyl choline hydrolysis measured at 240 ran, All specimens on which sufficient serum was available were referred to Veterans Administration Hospital, Hines, Illinois, where activities and dibucaine and fluoride numbers were determined according to the method of Dietz, Rubinstein and Lubrano (1973) using propionyl thiocholine at 37 °C.
RESULTS
The results obtained in the two laboratories from the 28 patients investigated are shown in table I. Reference ranges are included for comparison. There is complete agreement between the two laboratories on the interpretation of inhibitor studies and hence on the phenotypes which have been attributed. 
In none of the patients tested in this series was there evidence for a UF phenotype. Two were shown to be heterozygous for the usual and atypical enzyme forms, a condition which occurs in approximately 4% of Caucasian populations, and one heterozygous for the atypical and Kalow variants (AK). In the presence of inhibitors, the enzyme of the K variant has the same properties as usual cholinesterase and can be detected only if it segregates with a qualitative variant resistant to dibucaine or fluoride inhibition. In these circumstances, inhibitor numbers are obtained which are significantly different from those of other genetic combinations (Evans et al., 1980) . The frequency of the UF phenotype has been estimated at 1 in 200 in a population of British students (Whittaker, 1968) and if the MH subjects reflect the population at large, the absence of E, f is not surprising. It is extremely difficult to explain the differences between our results and those of other workers. They are unlikely to be a result of variations in populations examined, since one of the reports of a high UF frequency appeared from Leeds (Ellis, Cain et al., 1978) and was also based on patients referred to the local MH unit. In that report and now, patients came from many parts of the United Kingdom. Errors in analytical technique must seriously be considered as a possible cause of mistyping. The mechanism of fluoride inhibition of cholinesterase is complex (Heilbronn, 1965 ) and the measurement is liable to error. There is no doubt that the identification of the fluoride-resistant gene by laboratories inexperienced in cholinesterase methodology is likely to result in falsely positive and negative interpretations. No inhibitor numbers were quoted by Dr Whittaker and her colleagues, but in the communication from Ellis and others both fluoride and dibucaine numbers were reported. Their identification of phenotype depended solely upon fluoride number and no supporting evidence was forthcoming from the lower dibucaine numbers found in UF heterozygotes, which are well documented in the literature (Whittaker, 1980) and supported by our own experience.
We conclude that, until more substantial evidence to the contrary is forthcoming, the possibility of an increased frequency of the UF phenotype in patients susceptible to MH must be placed in serious doubt. 
SUMARIO
Se han efectuado cstudios de fenotipos de colinesterascs en dos laboratorios, en especimenes de sangre procedentes de 28 pacientes que mostraron ser susceptibles a la hiperpirexia maligna. En contraposition a los informes previamente publicados, no pudo encontrarse evidencia alguna relariva a un incremento en la frecuencia del genotipo E," E,' por encima de la que ya se conoce existe en la poblacion general.
